References
- Chiazze L., Brayer F. T., Macisco J. J., Parker M. P., Duffy B. J. The length and variability of the human menstrual cycle. Journal of the American Medical Association 1968; 203: 377–380
- Fotherby K., Howard G., Shrimanker K., Elder M., Bye P. Effect of norethisterone oenanthate on serum gonadotrophin levels. Contraception 1977; 16: 591–604
- Fotherby K., Howard G., Shrimanker K., Elder M., Bye P. Plasma levels of norethisterone after single and multiple injections of norethisterone oenanthate. Contraception 1978a; 18: 1–6
- Fotherby K., Howard G., Shrimanker K., Elder M., Bye P. Occurrence of ovulation in women receiving the injectable contraceptive norethisterone oenanthate. Contraception 1978b; 18: 535–542
- Fotherby K., Saxena B., Shrimanker K., Hingorani V., Takkar D., Diczfalusy E., Landgren B. M. A preliminary pharmacokinetic and phannacodynamic evaluation of depo-medroxyprogesterone acetate and norethisterone oenanthate. Fertility and Sterility 1980, (In the press)
- Goebelsmann U., Stanczyk F. Z., Brenner P. F., Goebelsmann A. E., Genzschein E. K. E., Mishell D. R. Serum norethindrone concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone. Contraception Jun., 1979; 19: 283–313
- Rinehart W., Winter J. Injectables and implants 1975, Population Reports. Series K, No. 1, K1–K16.
- Snowden R. The statistical analysis of menstrual bleeding patterns. Journal of Biosocial Sciences 1977; 9: 107–120
- Toppozada M., Parmar C., Fotherby K. Effect of injectable contraceptives Depo-Provera and norethisterone oenanthate on pituitary gonadotrophin response to luteinizing hormone releasing hormone. Fertility and Sterility 1978; 30: 545–548
- Treloar A. E., Boynton R. E., Behn B. G., Brown B. W. Variation in the human menstrual cycle through reproductive life. International Journal of Fertility 1967; 12: 77–87
- World Health Organization. Expanded programme of research, development and research training in human reproduction. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: norethisterone oenanthate and medroxyprogesterone acetate. 1. Use-effectiveness. Contraception 1977; 15: 513–533
- World Health Organization. Expanded programme of research, development and research training in human reproduction. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: norethisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects. Contraception 1978; 17: 395–406